Taiwan FDA registration 5bdba22d9963fddeae01ae3b9f4e3dab
Imno Consester's autologous antinuclear antibody screening enzyme immunotest reagent
TW: 伊姆諾康塞斯特自體抗核抗體篩選酵素免疫測試試劑
Taiwan·Risk Class 2·IMMUNO CONCEPTS NA LTD·Registered Feb 21, 2006 – Feb 21, 2016CancelledRegistration details
- Analysis ID
- 5bdba22d9963fddeae01ae3b9f4e3dab
- Customs Code
- DHA00601603900
Company information
- Manufacturer
- IMMUNO CONCEPTS NA LTD
- Manufacturer Country
- United States
- Authorized Representative
- GRANT TECHNOLOGY CO., LTD.
Product details
- Intended Use
- Detection of antinuclear antibodies in human serum.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.5100 抗核抗體免疫試驗系統
- Import Information
- import
Dates and status
- Registration Date
- Feb 21, 2006
- Expiry Date
- Feb 21, 2016
- Cancellation Date
- May 10, 2018
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Imno Consester's autologous antinuclear antibody screening enzyme immunotest reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 5bdba22d9963fddeae01ae3b9f4e3dab and manufactured by IMMUNO CONCEPTS NA LTD. The authorized representative in Taiwan is GRANT TECHNOLOGY CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices